Previous and/or concurrent clinical study experience

were currently enrolled in any other clinical study involving an investigational product or any other type of medical research judged not to be scientifically or medically compatible with this studywithin the past 30 days had participated in a clinical study and received treatment, whether active or placebo. If the study involved an investigational product, five half-lives or 30 days, whichever was longer, should have passed.had previously completed or withdrawn from this study or any other study investigating tirzepatide after receiving at least one dose of investigational product